INO
Inovio Pharmaceuticals Inc
Price:  
2.15 
USD
Volume:  
992,374.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

INO Relative Valuation

-3831.9%
Upside

As of 2025-02-17, the Relative Valuation of Inovio Pharmaceuticals Inc (INO) is (80.24) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.15 USD, the upside of Inovio Pharmaceuticals Inc based on Relative Valuation is -3831.9%.

The range of the Relative Valuation is (65.75) - (89.93) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 21.0x - 33.9x 27.4x
Forward P/E multiples 18.9x - 28.7x 23.8x
Fair Price (65.75) - (89.93) (80.24)
Upside -3158.3% - -4282.6% -3831.9%
2.15 USD
Stock Price
(80.24) USD
Fair Price

INO Relative Valuation - Historical P/E Data

Date P/E
2025-02-14 -0.69
2025-02-13 -0.68
2025-02-12 -0.68
2025-02-11 -0.61
2025-02-10 -0.61
2025-02-07 -0.63
2025-02-06 -0.64
2025-02-05 -0.65
2025-02-04 -0.63
2025-02-03 -0.64
2025-01-31 -0.67
2025-01-30 -0.67
2025-01-29 -0.65
2025-01-28 -0.70
2025-01-27 -0.72
2025-01-24 -0.70
2025-01-23 -0.73
2025-01-22 -0.72
2025-01-21 -0.70
2025-01-17 -0.66
2025-01-16 -0.61
2025-01-15 -0.59
2025-01-14 -0.60
2025-01-13 -0.61
2025-01-10 -0.63
2025-01-08 -0.67
2025-01-07 -0.73
2025-01-06 -0.62
2025-01-03 -0.63
2025-01-02 -0.58
2024-12-31 -0.58
2024-12-30 -0.57
2024-12-27 -0.60
2024-12-26 -0.59
2024-12-24 -0.58
2024-12-23 -0.57
2024-12-20 -0.59
2024-12-19 -0.59
2024-12-18 -0.57
2024-12-17 -0.63
2024-12-16 -0.69
2024-12-13 -0.74
2024-12-12 -1.20
2024-12-11 -1.29
2024-12-10 -1.29
2024-12-09 -1.32
2024-12-06 -1.33
2024-12-05 -1.28
2024-12-04 -1.32
2024-12-03 -1.34